Sun Pharma Launches Novel, Premixed, Ready-to-Infuse Formulation of Gemcitabine in the United States - Onco'Zine
Sun Pharma, a global specialty generic company based in Mumbai, India, which provides innovative, high-quality, affordable medicines trusted by physicians and patients in more than 100 countries around the world, announced that their novel, pre-mixed, formulation of gemcitabine for intravenous use, is now commercially available in the U.S.